NCT03017794View on ClinicalTrials.gov

Evaluation of Neuroendocrine Differentiation as a Potential Mechanism of Tumor Recurrence Following Radiotherapy

Active, not recruitingOBSERVATIONAL

Enrollment

118

Participants

Timeline

Start Date

January 4, 2017

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions

Prostate Cancer

Trial Locations (3)

55905

Mayo Clinic, Rochester

85259

Mayo Clinic in Arizona, Scottsdale

32224-9980

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER